C Dub805
Member
The more and more research I do, the more and more questions come to mind as to why so many people advocate running Nolvadex as the most appropriate measure for a PCT to H-Drol.
Now, please excuse my often overly-analytical approach to most things in life. I have questions and concerns, but at the same time, I remain receptive to any and all advice given by you, my fellow Anabolic Minds members.
It is said that H-Drol DOES NOT aromatize or convert to estrogen and although one's estrogen levels MAY rise slightly as a result of an H-Drol cycle, they will CERTAINLY NOT rise to a point where gyno will start setting in.
That said, why is Nolvadex being advocated as the most appropriate and absolute necessary PCT for and H-Drol cycle when Nolvadex (a SERM) primary purpose is to prevent gyno by competing for the receptor site in breast tissue and binding to it? The effect of tamoxifen citrate (Nolvadex); therefore, is through estrogen receptor blockade of breast tissue. Nolvadex is essentially recommended for those who use steroids THAT CONVERT TO ESTROGEN. Again, H-Drol doesn't convert to estrogen, so why Nolvadex as PCT?
Also, per the science, Nolvadex is the most effective PCT for PH's, Designer Steroids and Steroids THAT Aromatize or CONVERT TO ESTROGEN. Again, H-Drol, whether it be labeled a PH or DS does not convert to estrogen.
I look forward to your feedback and justification for including Nolvadex as the bread and butter of your H-Drol PCT cycle.
Now, please excuse my often overly-analytical approach to most things in life. I have questions and concerns, but at the same time, I remain receptive to any and all advice given by you, my fellow Anabolic Minds members.
It is said that H-Drol DOES NOT aromatize or convert to estrogen and although one's estrogen levels MAY rise slightly as a result of an H-Drol cycle, they will CERTAINLY NOT rise to a point where gyno will start setting in.
That said, why is Nolvadex being advocated as the most appropriate and absolute necessary PCT for and H-Drol cycle when Nolvadex (a SERM) primary purpose is to prevent gyno by competing for the receptor site in breast tissue and binding to it? The effect of tamoxifen citrate (Nolvadex); therefore, is through estrogen receptor blockade of breast tissue. Nolvadex is essentially recommended for those who use steroids THAT CONVERT TO ESTROGEN. Again, H-Drol doesn't convert to estrogen, so why Nolvadex as PCT?
Also, per the science, Nolvadex is the most effective PCT for PH's, Designer Steroids and Steroids THAT Aromatize or CONVERT TO ESTROGEN. Again, H-Drol, whether it be labeled a PH or DS does not convert to estrogen.
I look forward to your feedback and justification for including Nolvadex as the bread and butter of your H-Drol PCT cycle.